Biogen Idec Inc.'s Tecfidera OK'd in Europe for MS

Almost one year after its approval in the U.S., Biogen Idec's multiple sclerosis treatment Tecfidera has been approved in Europe.
 
 
 
  Reported by Motley Fool 5 hours ago.